OMAHA, Neb., March 5 /PRNewswire-FirstCall/ -- Transgenomic Inc. announces the following Webcast:
What: Transgenomic, Inc. Fourth Quarter 2006 Earnings Release Conference Call When: Thursday, March 8, 2007 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 800-896-8445 or 785-830-1916. A replay of the call will be available via telephone until 11:59 pm ET on Thursday, March 22, 2007. To access, dial 800-839-1229 or 402-220-0459.
About Transgenomic: A decade of discovery 1997 - 2007
Transgenomic is a global biotechnology company that provides unique systems, products, discovery and laboratory testing services to the academic and medical research, clinical and pharmaceutical markets for automated high sensitivity genetic variation and mutation analysis in the fields of pharmacogenomics and personalized medicine. This is accomplished through their offerings of WAVE(R) DHPLC Systems, reagents, consumables and assay kits, automated cytogenetics systems and Transgenomic Discovery and CLIA Lab Services. To date there have been over 1,200 WAVE systems installed in over 600 customer sites in over 35 countries and approximately 1,500 publications utilizing Transgenomic products or services. Transgenomic Discovery and Lab Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.
Transgenomic, Inc.CONTACT: Investor Relations of Transgenomic, Inc., +1-402-452-5400
Web site: http://www.transgenomic.com/
